Small biotech ends stealth mission to conduct gene edits without triggering immune system
Gene editing biotech NeuBase Therapeutics is stopping program development and looking for a sale after its board of directors voted to close up shop and seek strategic alternatives. | Gene editing biotech NeuBase Therapeutics is stopping program developmen...
https://www.fiercebiotech.com/biotech/small-biotech-ends-stealth-mission-conduct-gene-edits-without-triggering-immune-system